Recent guidelines advise the routine use of albumin only for patients with cirrhosis and ascites undergoing large-volume paracentesis, hepatorenal syndrome, and those with cirrhosis and spontaneous bacterial peritonitis.20Further studies need to investigate the role of albumin in reducing the volume of crystalloid fluid resuscitation and subsequent risk of FAS. The gene discussed is ALB; the disease is Ascites.